Sewoon Medical Statistics
Total Valuation
Sewoon Medical has a market cap or net worth of KRW 107.15 billion. The enterprise value is 18.90 billion.
| Market Cap | 107.15B |
| Enterprise Value | 18.90B |
Important Dates
The next estimated earnings date is Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Sewoon Medical has 43.29 million shares outstanding. The number of shares has decreased by -0.94% in one year.
| Current Share Class | 43.29M |
| Shares Outstanding | 43.29M |
| Shares Change (YoY) | -0.94% |
| Shares Change (QoQ) | -1.15% |
| Owned by Insiders (%) | 53.40% |
| Owned by Institutions (%) | 0.08% |
| Float | 20.17M |
Valuation Ratios
The trailing PE ratio is 9.24.
| PE Ratio | 9.24 |
| Forward PE | n/a |
| PS Ratio | 1.72 |
| PB Ratio | 0.71 |
| P/TBV Ratio | 0.73 |
| P/FCF Ratio | 6.96 |
| P/OCF Ratio | 6.38 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.29, with an EV/FCF ratio of 1.23.
| EV / Earnings | 1.64 |
| EV / Sales | 0.30 |
| EV / EBITDA | 1.29 |
| EV / EBIT | 1.67 |
| EV / FCF | 1.23 |
Financial Position
The company has a current ratio of 15.33, with a Debt / Equity ratio of 0.01.
| Current Ratio | 15.33 |
| Quick Ratio | 13.07 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.05 |
| Interest Coverage | 292.26 |
Financial Efficiency
Return on equity (ROE) is 8.08% and return on invested capital (ROIC) is 4.77%.
| Return on Equity (ROE) | 8.08% |
| Return on Assets (ROA) | 4.56% |
| Return on Invested Capital (ROIC) | 4.77% |
| Return on Capital Employed (ROCE) | 7.49% |
| Revenue Per Employee | 361.20M |
| Profits Per Employee | 66.92M |
| Employee Count | 172 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.26 |
Taxes
In the past 12 months, Sewoon Medical has paid 2.85 billion in taxes.
| Income Tax | 2.85B |
| Effective Tax Rate | 19.34% |
Stock Price Statistics
The stock price has decreased by -2.56% in the last 52 weeks. The beta is 0.69, so Sewoon Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -2.56% |
| 50-Day Moving Average | 2,433.80 |
| 200-Day Moving Average | 2,507.50 |
| Relative Strength Index (RSI) | 61.29 |
| Average Volume (20 Days) | 41,156 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sewoon Medical had revenue of KRW 62.13 billion and earned 11.51 billion in profits. Earnings per share was 267.99.
| Revenue | 62.13B |
| Gross Profit | 22.25B |
| Operating Income | 11.29B |
| Pretax Income | 14.73B |
| Net Income | 11.51B |
| EBITDA | 14.66B |
| EBIT | 11.29B |
| Earnings Per Share (EPS) | 267.99 |
Balance Sheet
The company has 92.15 billion in cash and 808.44 million in debt, giving a net cash position of 91.34 billion or 2,109.90 per share.
| Cash & Cash Equivalents | 92.15B |
| Total Debt | 808.44M |
| Net Cash | 91.34B |
| Net Cash Per Share | 2,109.90 |
| Equity (Book Value) | 150.08B |
| Book Value Per Share | 3,459.45 |
| Working Capital | 115.84B |
Cash Flow
In the last 12 months, operating cash flow was 16.79 billion and capital expenditures -1.39 billion, giving a free cash flow of 15.40 billion.
| Operating Cash Flow | 16.79B |
| Capital Expenditures | -1.39B |
| Free Cash Flow | 15.40B |
| FCF Per Share | 355.82 |
Margins
Gross margin is 35.82%, with operating and profit margins of 18.17% and 18.53%.
| Gross Margin | 35.82% |
| Operating Margin | 18.17% |
| Pretax Margin | 23.71% |
| Profit Margin | 18.53% |
| EBITDA Margin | 23.60% |
| EBIT Margin | 18.17% |
| FCF Margin | 24.79% |
Dividends & Yields
This stock pays an annual dividend of 60.00, which amounts to a dividend yield of 2.42%.
| Dividend Per Share | 60.00 |
| Dividend Yield | 2.42% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 22.57% |
| Buyback Yield | 0.94% |
| Shareholder Yield | 3.37% |
| Earnings Yield | 10.74% |
| FCF Yield | 14.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 24, 2009. It was a forward split with a ratio of 2.
| Last Split Date | Sep 24, 2009 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Sewoon Medical has an Altman Z-Score of 10.39 and a Piotroski F-Score of 4.
| Altman Z-Score | 10.39 |
| Piotroski F-Score | 4 |